COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies
Authors
Keywords
COX2, COVID-19, Immunomodulation, Coronavirus, Celecoxib
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 101, Issue -, Pages 29-32
Publisher
Elsevier BV
Online
2020-09-30
DOI
10.1016/j.ijid.2020.09.1466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition
- (2020) Aleix Gimeno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chloroquine and hydroxychloroquine in covid-19
- (2020) Robin E Ferner et al. BMJ-British Medical Journal
- Covid-19—The real role of NSAIDs in Italy
- (2020) Laura de Girolamo et al. Journal of Orthopaedic Surgery and Research
- Artificial intelligence approach fighting COVID-19 with repurposing drugs
- (2020) Yi-Yu Ke et al. Biomedical Journal
- Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study
- (2020) Lars Christian Lund et al. PLOS MEDICINE
- Lysophosphatidylcholine-induced mitochondrial fission contributes to collagen production in human cardiac fibroblasts
- (2019) Hui-Ching Tseng et al. JOURNAL OF LIPID RESEARCH
- The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus
- (2019) To Sing Fung et al. VIROLOGY
- Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride–Induced Model of Liver Injury
- (2018) Todd R. Harris et al. MOLECULAR PHARMACOLOGY
- Attenuation of antimalarial agent hydroxychloroquine on TNF-α-induced endothelial inflammation
- (2018) Ruiru Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lipoxin B4 Enhances Human Memory B Cell Antibody Production via Upregulating Cyclooxygenase-2 Expression
- (2018) Nina Kim et al. JOURNAL OF IMMUNOLOGY
- Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project
- (2018) Gwen M. C. Masclee et al. PLoS One
- Inhibition of P38 MAPK Downregulates the Expression of IL-1βto Protect Lung from Acute Injury in Intestinal Ischemia Reperfusion Rats
- (2016) De-Yi Zheng et al. MEDIATORS OF INFLAMMATION
- Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
- (2016) Steven E. Nissen et al. NEW ENGLAND JOURNAL OF MEDICINE
- SB203580 inhibits epithelial–mesenchymal transition and pulmonary fibrosis in a rat silicosis model
- (2016) Wang Yan et al. TOXICOLOGY LETTERS
- Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes
- (2014) Shi-Lei Wen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Coronavirus-induced ER stress response and its involvement in regulation of coronavirus–host interactions
- (2014) To Sing Fung et al. VIRUS RESEARCH
- Hyperoxia and Interferon-γ–Induced Injury in Developing Lungs Occur via Cyclooxygenase-2 and the Endoplasmic Reticulum Stress–Dependent Pathway
- (2013) Rayman Choo-Wing et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection
- (2011) Li Liu et al. CLINICA CHIMICA ACTA
- Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
- (2010) Michelle A. Carey et al. PLoS One
- Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis
- (2009) P. Fabbrini et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hyperinduction of Cyclooxygenase‐2–Mediated Proinflammatory Cascade: A Mechanism for the Pathogenesis of Avian Influenza H5N1 Infection
- (2008) Suki M. Y. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Insights into Inflammation and Influenza
- (2008) Cameron Simmons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
- (2008) B.-J. Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
- (2007) Masakazu Kono et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now